• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Cameroon Pharmaceuticals and Healthcare Report Q1 2013 - Product Image

Cameroon Pharmaceuticals and Healthcare Report Q1 2013

  • ID: 2356171
  • December 2012
  • Region: Cameroon
  • 38 pages
  • Business Monitor International

BMI View: Cameroon will continue to languish near the bottom of our proprietary Pharmaceutical Risk/Reward Ratings for the Middle East and Africa region due to the country’s low per capita healthcare and pharmaceutical expenditure, as well as the overall low pharmaceutical expenditure. The situation is further complicated by poor intellectual property protection, slow approval processes and rampant corruption. Consequently we do not expect the market to be of significant interest to multinational pharmaceutical firms.

Headline Expenditure Projections:

- Pharmaceuticals: XAF106.7bn (US$226mn) in 2011 to XAF114.9bn (US$223mn) in 2012;
+7.7% in local currency terms and -1.4% in US dollar terms. Forecast broadly unchanged from Q412.

- Healthcare: XAF642.8bn (US$1.36bn) in 2011 to XAF697.1bn (US$1.35bn) in 2012; +8.4% in local currency terms and -0.7% in US dollar terms. Forecast broadly unchanged from Q412.

Risk/Reward Ratings: With a RRR score of 31.5, a decline from 34.2 in Q412, Cameroon slipped from 26th to 27th place this quarter within the 30-country MEA region. Key threats in the pharmaceutical market remain, such as rampant corruption, low per READ MORE >

Executive Summary 5

Pharmaceutical Risk/Reward Ratings 7
Table: MEA Pharmaceuticals And Healthcare Risk/Reward Ratings, Q113 7

Rewards 9

Risks 9

Cameroon – Market Overview 11

Regulatory Regime 12

Industry Forecast Scenario 13

Overall Market Forecast 13
Table: Pharmaceutical Sales Indicators, 2008-2016 15

Key Growth Factors – Healthcare 16
Table: Healthcare Expenditure Indicators, 2008-2016 19
Table: Healthcare Governmental Indicators, 2008-2016 19
Table: Healthcare Private Indicators, 2008-2016 20

Key Growth Factors – Macroeconomic 21
Table: Cameroon – Economic Activity 25

Competitive Landscape 26

Industry And Company Developments 26

Demographic Outlook 28
Table: Population By Age Group, 1990-2020 (‘000) 29
Table: Population By Age Group, 1990-202 0 (% of total) 30
Table: Key Population Ratios, 1990-2020 31
Table: Rural/Urban Population Split, 1990-2020 31

Glossary 32

BMI Methodology 34

How We Generate Our Pharmaceutical Industry Forecasts 34

Pharmaceutical Risk/Reward Ratings Methodology 35

Ratings Overview 35
Table: Pharmaceutical Risk/Reward Indicators 36

Weighting 37
Table: Weighting Of Components 37

Sources 37

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos